MLA
BKV

MB, Levis & Associates’s BKV Corp BKV Stock Holding History

MB, Levis & Associates’s Portfolio BKV Stock Details BKV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-250
Closed -$6.79K – 255
2025
Q4 		$6.79K Buy
+250
New +$6.28K ﹤0.01% 175

Other funds holding BKV

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MB, Levis & Associates's BKV Position: Q1 2026 in Review

MB, Levis & Associates sold out of BKV Corp (BKV) in Q1 2026, closing a stake of 250 shares — an estimated $6.79K sold.

MB, Levis & Associates first reported a position in BKV in Q4 2025 and held it in 1 quarter. The position peaked at $6.79K in Q4 2025. 167 funds tracked by Wall St. Rank hold BKV as of Q1 2026.

  • MB, Levis & Associates reported no remaining BKV Corp position as of Q1 2026 after selling out during the quarter.
  • MB, Levis & Associates sold 250 BKV Corp shares in Q1 2026, an estimated $6.79K.
  • MB, Levis & Associates first reported a position in BKV Corp in Q4 2025 and held it in 1 quarter.
  • MB, Levis & Associates's BKV Corp position peaked at $6.79K in Q4 2025.
  • 167 funds tracked by Wall St. Rank held BKV Corp as of Q1 2026.

Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.